Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Solo-Dex
Wolf Creek, Montana, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Solo-Dex’s Fascile Continuous Peripheral Nerve Block (cPNB) catheter system is FDA-cleared and CE-marked, used in over 7,000 patients for opioid-free post-surgical pain management. The device is clinically proven and validated by leading institutions for effective regional anesthesia, enabling up to 72 hours of pain control and a reduction in opioid use post-surgery[1][2][3].
- Therapeutic areas
- OtherNeurology
- Modalities
- Device
- Industry
- Surgical Medical Devices
02
Partnerships
CH Trading Group LLCFarouk, Maamoun Tamer & Co.
Beyond the preview
Go deeper on Solo-Dex.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Solo-Dex.